← FDA Drug Approvals (Drugs@FDA)

FEMLYV

NDA · New Drug Application · Sponsor: MILLICENT PR · Approved 2024-07-22

Drug application

FDA Application #

NDA218718

Application type

New Drug Application

Brand name

FEMLYV

Generic name

NORETHINDRONE ACETATE/ETHINYL ESTRADIOL

Active ingredients

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Prescription

Sponsor

MILLICENT PR

Manufacturer

Millicent US, Inc.

First approval

2024-07-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown